Sign inGet started

Lochner Daniel

Insider CIK 1791187 · TECX Chief Financial Officer · OYST Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TECX Tectonic Therapeutic, Inc. F Tax w/h2026-09-252026-10-02520$23.67 $12.3K58,024SEC↗
TECX Tectonic Therapeutic, Inc. A Award deriv2026-09-032026-09-0824,250— $024,250SEC↗
TECX Tectonic Therapeutic, Inc. A Award deriv2026-09-032026-09-0824,250— $024,250SEC↗
TECX Tectonic Therapeutic, Inc. A Award deriv2026-06-112026-06-127,500— $07,500SEC↗
TECX Tectonic Therapeutic, Inc. A Award deriv2026-03-042026-03-0524,250— $024,250SEC↗
TECX Tectonic Therapeutic, Inc. A Award2026-03-042026-03-0526,500— $058,544SEC↗
TECX Tectonic Therapeutic, Inc. P Buy2026-02-102026-02-116,000$21.61 $129.7K32,044SEC↗
TECX Tectonic Therapeutic, Inc. F Tax w/h2026-02-042026-02-102,077$23.22 $48.2K26,044SEC↗
TECX Tectonic Therapeutic, Inc. A Award deriv2025-09-252025-09-299,860— $09,860SEC↗
TECX Tectonic Therapeutic, Inc. A Award2025-09-252025-09-295,430— $028,121SEC↗
TECX Tectonic Therapeutic, Inc. P Buy2025-02-052025-02-074,617$54.14 $250.0K4,617SEC↗
TECX Tectonic Therapeutic, Inc. A Award deriv2025-02-042025-02-0632,862— $032,862SEC↗
TECX Tectonic Therapeutic, Inc. A Award2025-02-042025-02-0618,074— $018,074SEC↗
TECX Tectonic Therapeutic, Inc. A Award deriv2024-06-202024-06-24118,000— $0118,000SEC↗
OYST Oyster Point Pharma, Inc. D To issuer deriv2023-01-032023-01-04161,251— $00SEC↗
OYST Oyster Point Pharma, Inc. D To issuer deriv2023-01-032023-01-0472,648— $00SEC↗
OYST Oyster Point Pharma, Inc. D To issuer deriv2023-01-032023-01-0450,500— $00SEC↗
OYST Oyster Point Pharma, Inc. D To issuer deriv2023-01-032023-01-04300,000— $00SEC↗
OYST Oyster Point Pharma, Inc. D To issuer deriv2023-01-032023-01-0445,000— $00SEC↗
OYST Oyster Point Pharma, Inc. D To issuer deriv2023-01-032023-01-0487,900— $00SEC↗
OYST Oyster Point Pharma, Inc. U Tender2023-01-032023-01-0456,289— $020,236SEC↗
OYST Oyster Point Pharma, Inc. D To issuer2023-01-032023-01-0420,236— $00SEC↗
OYST Oyster Point Pharma, Inc. F Tax w/h2022-12-012022-12-063,258$11.20 $36.5K74,463SEC↗
OYST Oyster Point Pharma, Inc. A Award deriv2022-07-062022-07-08300,000— $0300,000SEC↗
OYST Oyster Point Pharma, Inc. F Tax w/h2022-01-292023-01-04938$11.70 $11.0K76,525SEC↗
OYST Oyster Point Pharma, Inc. A Award deriv2022-01-092022-01-1187,900— $087,900SEC↗
OYST Oyster Point Pharma, Inc. A Award2022-01-092022-01-1119,500— $077,721SEC↗
OYST Oyster Point Pharma, Inc. M Exercise deriv2021-11-012021-11-028,590— $0161,251SEC↗
OYST Oyster Point Pharma, Inc. M Exercise2021-11-012021-11-028,590$11.51 $98.9K58,221SEC↗
OYST Oyster Point Pharma, Inc. M Exercise deriv2021-09-022021-09-077,500— $0169,841SEC↗
OYST Oyster Point Pharma, Inc. M Exercise2021-09-022021-09-077,500$11.51 $86.3K49,631SEC↗
OYST Oyster Point Pharma, Inc. A Award deriv2021-08-262021-08-3045,000— $045,000SEC↗
OYST Oyster Point Pharma, Inc. M Exercise deriv2021-07-282021-07-297,500— $0177,341SEC↗
OYST Oyster Point Pharma, Inc. M Exercise2021-07-282021-07-297,500$11.51 $86.3K42,131SEC↗
OYST Oyster Point Pharma, Inc. M Exercise deriv2021-02-242021-02-269,109— $0184,841SEC↗
OYST Oyster Point Pharma, Inc. M Exercise2021-02-242021-02-269,109$11.51 $104.8K34,631SEC↗
OYST Oyster Point Pharma, Inc. A Award deriv2021-01-292021-02-0250,500— $050,500SEC↗
OYST Oyster Point Pharma, Inc. A Award2021-01-292021-02-0211,222— $025,522SEC↗
OYST Oyster Point Pharma, Inc. M Exercise deriv2020-09-252020-09-284,000— $0193,950SEC↗
OYST Oyster Point Pharma, Inc. M Exercise2020-09-252020-09-284,000$11.51 $46.0K14,300SEC↗
OYST Oyster Point Pharma, Inc. M Exercise deriv2020-08-112020-08-124,000— $0197,950SEC↗
OYST Oyster Point Pharma, Inc. M Exercise2020-08-112020-08-124,000$11.51 $46.0K4,000SEC↗
OYST Oyster Point Pharma, Inc. M Exercise2020-08-112020-08-184,000$11.51 $46.0K10,300SEC↗
OYST Oyster Point Pharma, Inc. A Award deriv2020-02-032020-02-0572,648— $072,648SEC↗
OYST Oyster Point Pharma, Inc. P Buy2019-11-042019-11-056,300$16.00 $100.8K6,300SEC↗